Clinical Trials Browser

Withdrawn × Pancreatic Neoplasms × durvalumab × Clear all

NCT03038477 2020-09-14

A Study of Durvalumab in Patients With BR PDA Following Neoadjuvant Therapy and Successful Surgical Resection

Phase 2 Withdrawn

Gastrointestinal

Pancreatic Neoplasms

NCT02885727 2019-09-12

Panc-Durval+RT

Phase 2 Withdrawn

Gastrointestinal

Pancreatic Neoplasms

NCT02868632 2019-04-05

Study of Immune Checkpoint Inhibition With Radiation Therapy in Unresectable, Non-metastatic Pancreatic Cancer

Phase 1 Withdrawn

Gastrointestinal

Pancreatic Neoplasms